Zegalogue is used for treating severe hypoglycaemia (low blood glucose levels) in adults and children from 6 years of age who have diabetes mellitus. Hypoglycaemia can occur when diabetes medicines cause glucose levels to fall too low. In severe cases, patients can faint or become unconscious, and they must be treated urgently to raise their glucose levels. Zegalogue contains the active substance dasiglucagon.
Therapeutic Indication
### Therapeutic indication Zegalogue is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 6 years and over with diabetes mellitus.
Therapeutic Area (MeSH)
N/AATC Code
H04AA02
ATC Item
dasiglucagon
Pharmacotherapeutic Group
Pancreatic hormones
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| dasiglucagon hydrochloride | N/A | dasiglucagon hydrochloride |
EMA Name
Zegalogue
Medicine Name
Zegalogue
Aliases
N/ANo risk management plan link.
